A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the clinical efficacy and safety in patients with Laryngopharyngitis or
Tonsillitis or Acute Bacterial Rhinosinusitis receiving a dose of 2 g of azithromycin in the
SR formulation.